Literature DB >> 10121

Absorption and malabsorption of folates.

I H Rosenberg.   

Abstract

Folic acid is one of the 'younger' vitamins, yet it has attracted intensive study in the thirty years since the identification of pteroylglutamic acid and its polyglutamyl conjugates. The absorption and malabsorption of folates, natural, purified and synthetic, in disease has been studied more than any other vitamin and indeed folate absorption has become one clinical test of intestinal function. We know little about the release of folate from protein complexes, but we have learned, with the help of synthetic radiolabelled pteroylpolyglutamates that polyglutamyl folates are hydrolysed at or near the luminal border of the intestine and the released folate is efficiently absorbed. The rate limiting stage of folate absorption appears to be the transport of the monoglutamyl folate. In disease, and with drugs, folate malabsorption occurs primarily when monoglutamyl transport is depressed. The specific components of the folate transport system, listed in Table 4, are receiving increased attention. The mechanism of uptake is still a topic of controversy but a dual system including both a saturable and a diffusion component would explain most of the data. Reduction and methyl or formyl addition occur in the intestine but such metabolism is not obligatory for transport. The nature of folate binding within the cell and the function of specific folate binding proteins requires further study. At present we have little or no information about the mechanism of folate release from the epithelial cell to the circulation but this step also could influence the rate and specificity of overall process. The tools are now at hand to complete our understanding of the steps in folate absorption and metabolism. Such an understanding should facilitate the management of folate deficiency whenever it complicates gastrointestinal disease or drug therapy.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10121

Source DB:  PubMed          Journal:  Clin Haematol        ISSN: 0308-2261


  10 in total

1.  Inhibition of folate enzymes by sulfasalazine.

Authors:  J Selhub; G J Dhar; I H Rosenberg
Journal:  J Clin Invest       Date:  1978-01       Impact factor: 14.808

2.  Intestinal lesions induced experimentally by methotrexate.

Authors:  A Baskerville; D Batter-Hatton
Journal:  Br J Exp Pathol       Date:  1977-12

3.  Impairment of folic acid absorption by oral pancreatic extracts.

Authors:  R M Russell; S K Dutta; E V Oaks; I H Rosenberg; A C Giovetti
Journal:  Dig Dis Sci       Date:  1980-05       Impact factor: 3.199

4.  Intestinal folic acid absorption and the acid microclimate. The effects of compounds relevant to folate malabsorption.

Authors:  J A Blair; M L Lucas; S K Swanston-Flatt
Journal:  Pflugers Arch       Date:  1981-11       Impact factor: 3.657

5.  Congenital folate malabsorption.

Authors:  L Corbeel; G Van den Berghe; J Jaeken; J Van Tornout; R Eeckels
Journal:  Eur J Pediatr       Date:  1985-03       Impact factor: 3.183

6.  Availability of monoglutamyl and polyglutamyl folates in normal subjects and in patients with coeliac sprue.

Authors:  C H Halsted; A M Reisenauer; B Shane; T Tamura
Journal:  Gut       Date:  1978-10       Impact factor: 23.059

7.  Inhibitory effect of unconjugated bile acids on the intestinal transport of 5-methyltetrahydrofolate in rat jejunum in vitro.

Authors:  H M Said; D Hollander; W B Strum
Journal:  Gut       Date:  1984-12       Impact factor: 23.059

8.  The effect of inhibitors of folic acid absorption on the transfer rate constants in the rat everted proximal jejunum: a method for their evaluation from a three-compartment model.

Authors:  M L Lucas; S K Swanston-Flatt; J A Blair
Journal:  J Pharmacokinet Biopharm       Date:  1982-12

9.  Jejunal perfusion of simple and conjugated folates in celiac sprue.

Authors:  C H Halsted; A M Reisenauer; J J Romero; D S Cantor; B Ruebner
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

10.  Is folate absorption impaired by high dose methotrexate?

Authors:  C R Pinkerton
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.